.jpg)
.png)
This Expert Clinical Review highlights the importance of a collaborative approach to the management of dyslipidemia and other cardiometabolic risk factors, including improved diagnosis and treatment, enhanced access to facilitation of lifestyle interventions, the optimization of pharmacotherapy, and patient education and empowerment.
